Compounds > 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide
Page last updated: 2024-09-02

4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide and Kidney Diseases

4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aitio, ML; Allonen, H; Kanto, J; Mäntylä, R1

Other Studies

1 other study(ies) available for 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide and Kidney Diseases

ArticleYear
The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
    International journal of clinical pharmacology, therapy, and toxicology, 1982, Volume: 20, Issue:5

    Topics: Administration, Oral; Adult; Disopyramide; Female; Humans; Hydrogen-Ion Concentration; Injections, Intramuscular; Injections, Intravenous; Kidney Diseases; Kinetics; Male; Protein Binding; Pyridines

1982